109 related articles for article (PubMed ID: 21821875)
1. The radical scavenger IAC (bis(1-hydroxy-2,2,6,6-tetramethyl-4-piperidinyl) decantionate) decreases mortality, enhances cognitive functions in water maze and reduces amyloid plaque burden in hAβPP transgenic mice.
Puoliväli J; Nurmi A; Miettinen TK; Soleti A; Riccardino F; Kalesnykas G; Heikkinen T; Vartiainen N; Pussinen R; Tähtivaara L; Lehtimäki K; Yrjänheikki J; Canistro D; Sapone A; Spisni E; Paolini M
J Alzheimers Dis; 2011; 27(3):499-510. PubMed ID: 21821875
[TBL] [Abstract][Full Text] [Related]
2. Soluble Aβ levels correlate with cognitive deficits in the 12-month-old APPswe/PS1dE9 mouse model of Alzheimer's disease.
Zhang W; Hao J; Liu R; Zhang Z; Lei G; Su C; Miao J; Li Z
Behav Brain Res; 2011 Sep; 222(2):342-50. PubMed ID: 21513747
[TBL] [Abstract][Full Text] [Related]
3. Possible involvement of transthyretin in hippocampal beta-amyloid burden and learning behaviors in a mouse model of Alzheimer's disease (TgCRND8).
Doggui S; Brouillette J; Chabot JG; Farso M; Quirion R
Neurodegener Dis; 2010; 7(1-3):88-95. PubMed ID: 20173334
[TBL] [Abstract][Full Text] [Related]
4. Estrogen treatment improves spatial learning in APP + PS1 mice but does not affect beta amyloid accumulation and plaque formation.
Heikkinen T; Kalesnykas G; Rissanen A; Tapiola T; Iivonen S; Wang J; Chaudhuri J; Tanila H; Miettinen R; Puoliväli J
Exp Neurol; 2004 May; 187(1):105-17. PubMed ID: 15081593
[TBL] [Abstract][Full Text] [Related]
5. A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-beta-associated cognitive impairment.
Leon WC; Canneva F; Partridge V; Allard S; Ferretti MT; DeWilde A; Vercauteren F; Atifeh R; Ducatenzeiler A; Klein W; Szyf M; Alhonen L; Cuello AC
J Alzheimers Dis; 2010; 20(1):113-26. PubMed ID: 20164597
[TBL] [Abstract][Full Text] [Related]
6. LMN diet, rich in polyphenols and polyunsaturated fatty acids, improves mouse cognitive decline associated with aging and Alzheimer's disease.
Fernández-Fernández L; Comes G; Bolea I; Valente T; Ruiz J; Murtra P; Ramirez B; Anglés N; Reguant J; Morelló JR; Boada M; Hidalgo J; Escorihuela RM; Unzeta M
Behav Brain Res; 2012 Mar; 228(2):261-71. PubMed ID: 22119712
[TBL] [Abstract][Full Text] [Related]
7. Cycloxygenase-2 activity promotes cognitive deficits but not increased amyloid burden in a model of Alzheimer's disease in a sex-dimorphic pattern.
Melnikova T; Savonenko A; Wang Q; Liang X; Hand T; Wu L; Kaufmann WE; Vehmas A; Andreasson KI
Neuroscience; 2006 Sep; 141(3):1149-62. PubMed ID: 16753269
[TBL] [Abstract][Full Text] [Related]
8. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.
Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT
Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077
[TBL] [Abstract][Full Text] [Related]
9. Episodic-like memory deficits in the APPswe/PS1dE9 mouse model of Alzheimer's disease: relationships to beta-amyloid deposition and neurotransmitter abnormalities.
Savonenko A; Xu GM; Melnikova T; Morton JL; Gonzales V; Wong MP; Price DL; Tang F; Markowska AL; Borchelt DR
Neurobiol Dis; 2005 Apr; 18(3):602-17. PubMed ID: 15755686
[TBL] [Abstract][Full Text] [Related]
10. Progressive cognitive impairment and anxiety induction in the absence of plaque deposition in C57BL/6 inbred mice expressing transgenic amyloid precursor protein.
Lee KW; Lee SH; Kim H; Song JS; Yang SD; Paik SG; Han PL
J Neurosci Res; 2004 May; 76(4):572-80. PubMed ID: 15114629
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal behavioral changes in the APP/PS1 transgenic Alzheimer's disease model.
Ferguson SA; Sarkar S; Schmued LC
Behav Brain Res; 2013 Apr; 242():125-34. PubMed ID: 23295401
[TBL] [Abstract][Full Text] [Related]
12. D-Ala2GIP facilitated synaptic plasticity and reduces plaque load in aged wild type mice and in an Alzheimer's disease mouse model.
Faivre E; Hölscher C
J Alzheimers Dis; 2013; 35(2):267-83. PubMed ID: 23568101
[TBL] [Abstract][Full Text] [Related]
13. Chronic treatment with the α2-adrenoceptor antagonist fluparoxan prevents age-related deficits in spatial working memory in APP×PS1 transgenic mice without altering β-amyloid plaque load or astrocytosis.
Scullion GA; Kendall DA; Marsden CA; Sunter D; Pardon MC
Neuropharmacology; 2011; 60(2-3):223-34. PubMed ID: 20850464
[TBL] [Abstract][Full Text] [Related]
14. Use of multimetric statistical analysis to characterize and discriminate between the performance of four Alzheimer's transgenic mouse lines differing in Abeta deposition.
Leighty RE; Nilsson LN; Potter H; Costa DA; Low MA; Bales KR; Paul SM; Arendash GW
Behav Brain Res; 2004 Aug; 153(1):107-21. PubMed ID: 15219712
[TBL] [Abstract][Full Text] [Related]
15. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease.
Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS
J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767
[TBL] [Abstract][Full Text] [Related]
16. Obovatol improves cognitive functions in animal models for Alzheimer's disease.
Choi DY; Lee JW; Peng J; Lee YJ; Han JY; Lee YH; Choi IS; Han SB; Jung JK; Lee WS; Lee SH; Kwon BM; Oh KW; Hong JT
J Neurochem; 2012 Mar; 120(6):1048-59. PubMed ID: 22212065
[TBL] [Abstract][Full Text] [Related]
17. FK506 reduces amyloid plaque burden and induces MMP-9 in AβPP/PS1 double transgenic mice.
Hong HS; Hwang JY; Son SM; Kim YH; Moon M; Inhee MJ
J Alzheimers Dis; 2010; 22(1):97-105. PubMed ID: 20847451
[TBL] [Abstract][Full Text] [Related]
18. Ameliorative effects of yokukansan, a traditional Japanese medicine, on learning and non-cognitive disturbances in the Tg2576 mouse model of Alzheimer's disease.
Tabuchi M; Yamaguchi T; Iizuka S; Imamura S; Ikarashi Y; Kase Y
J Ethnopharmacol; 2009 Feb; 122(1):157-62. PubMed ID: 19146938
[TBL] [Abstract][Full Text] [Related]
19. The neuroprotective effects of Cerebrolysin in a transgenic model of Alzheimer's disease are associated with improved behavioral performance.
Rockenstein E; Adame A; Mante M; Moessler H; Windisch M; Masliah E
J Neural Transm (Vienna); 2003 Nov; 110(11):1313-27. PubMed ID: 14628195
[TBL] [Abstract][Full Text] [Related]
20. Clioquinol reduces zinc accumulation in neuritic plaques and inhibits the amyloidogenic pathway in AβPP/PS1 transgenic mouse brain.
Wang T; Wang CY; Shan ZY; Teng WP; Wang ZY
J Alzheimers Dis; 2012; 29(3):549-59. PubMed ID: 22269164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
